BioXcel Therapeutics (BTAI) Return on Assets (2018 - 2026)

BioXcel Therapeutics' Return on Assets history runs 9 years deep, the most recent figure standing at 0.02% for Q1 2026.

• In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (changed 0.0% YoY), while the FY2025 annual figure was 0.02%, changed 0.0% from the prior year.
• Return on Assets was 0.02% for Q1 2026 at BioXcel Therapeutics, down from 0.01% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2022 to a low of 0.02% in Q4 2023.
• Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.02% in 2024.
• The sharpest annual moves came in 2022 and 2023: Return on Assets changed 0 bps in 2022, then slipped 1 bps in 2023.
• A 5-year view of Return on Assets shows it stood at 0.01% in 2022, then slumped by 179 bps to 0.02% in 2023, then climbed by 11 bps to 0.02% in 2024, then gained by 19 bps to 0.01% in 2025, then decreased by 13 bps to 0.02% in 2026.
• The last three Return on Assets figures came in at 0.02% (Q1 2026), 0.01% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.